Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.4226
-0.0002 (-0.05%)
At close: Mar 16, 2026, 4:00 PM EDT
0.4142
-0.0084 (-1.99%)
After-hours: Mar 16, 2026, 6:51 PM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $14.55 million as of March 16, 2026. Its market cap has decreased by -32.49% in one year.
Market Cap
14.55M
Enterprise Value
13.70M
1-Year Change
-32.49%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $14.55M, a decrease of -89.01%. That is a compound annual growth rate of -82.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 14.55M | -58.57% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 15.98M |
| Hoth Therapeutics | 15.98M |
| Cadrenal Therapeutics | 15.36M |
| AEON Biopharma | 15.32M |
| Cocrystal Pharma | 14.20M |
| Polyrizon | 14.02M |
| IO Biotech | 13.78M |
| Phio Pharmaceuticals | 13.59M |